Global HP (High Potency) APIs Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

19 Nov, 2021

Check out TBRC’s sale today for

The high potency APIs (HPAPI) market consists of sales of high potency active pharmaceutical ingredients and related services. High potency APIs are extremely effective in pharmacologically active ingredients. These are highly specific in their action and offer significant efficiency even at the low daily therapeutic doses. HPAPIs are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells.

Global HP (High Potency) APIs Market Size And Drivers:

The global High Potency APIs market is expected to grow from $19.27 billion in 2020 to $20.3 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The high potency APIs market is expected to reach $27.3 billion in 2025 at a CAGR of 7.7%. The rising number of cancer cases coupled with increasing sales of cancer drugs contributed to the growth of the high potency APIs market.

Request For A Sample For The Global HP (High Potency) APIs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2814&type=smp

Trends In The Global HP (High Potency) APIs Market

The companies dealing in the high potency APIs market are focusing on strategies such as production facility expansion and mergers & acquisitions to maintain their position in the competitive business environment. For instance, in June 2019, a Swiss-based chemicals and biotechnology company Lonza declared an investment in the expansion of HPAPI capability at its location in Visp, Switzerland, by connecting additional 4-m3-scale and multi-purpose manufacturing lines. The expansion enhances the current manufacturing ability of the business from the laboratory to the broad commercial level and further includes the resulting utilization of capacity in existing manufacturing facilities. In January 2020, Piramal Pharma Solutions (PPS) declared an expenditure of $19 million to enhance its operation in Aurora, Ontario, Canada, with an additional 975 m2 of production space in a new wing for API production, including the production of HPAPI for potent compounds down to an OEL of 1 mcg/m3.

Global HP (High Potency) APIs Market Segments:
The global HPAPIs market is further segmented –
By Type: Innovative HPAPI, Generic HPAPI
By Synthesis Type: Synthetic HPAPI, Biotech HPAPI
By Therapeutic Application: Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, And Erectile Dysfunction)
By Geography: The global high potency APIs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global HP (High Potency) APIs Market At:

https://www.thebusinessresearchcompany.com/report/HP-high-potency-apis-market-global-report-2020-30-covid-19-impact-and-recovery

HP (High Potency) APIs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides HP (high potency) APIs market overviews, analyzes and forecasts market size and growth for the global HP (high potency) APIs market, HP (high potency) APIs market share, HP (high potency) APIs market players, HP (high potency) APIs market segments and geographies, HP (high potency) APIs market’s leading competitors’ revenues, profiles and market shares. The HP (high potency) APIs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.